A detailed history of Uma Financial Services, Inc. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Uma Financial Services, Inc. holds 76 shares of DNLI stock, worth $1,325. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76
Previous 140 45.71%
Holding current value
$1,325
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

SELL
$12.75 - $15.65 $816 - $1,001
-64 Reduced 45.71%
76 $1,000
Q2 2025

Jul 11, 2025

BUY
$11.47 - $16.65 $1,605 - $2,331
140 New
140 $1,000

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.34B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Uma Financial Services, Inc. Portfolio

Follow Uma Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uma Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Uma Financial Services, Inc. with notifications on news.